Category Archives: Compliance

Controlled Drug Take Back Event

The Environmental Health and Safety Office in conjunction with the Emory Office of Compliance and under the supervision of the Georgia Drugs and Narcotics Agency will host a Controlled Drug Take Back Day for drugs used in research.  This event is limited to schedule CI-CV drugs from authorized research users.  The event will take place on December 15, 2015 between the hours of 10am and 2pm at the Whitehead […]

Also posted in Announcements, EHSO | Tagged , , | Leave a comment

From The Office of Compliance…Ivan Oransky, MD Presents: Retraction Watch

Retraction watch has become famous in the world of academic research for examining the self-correcting nature of science by publicizing the retraction of academic journal articles and digging into the stories behind the retractions.  Dr.  Oransky is co-founder of Retraction Watch and also teaches medical journalism at New York University’s Science Health and Environmental Reporting […]

Also posted in ORA | Comments closed

Need Assistance With Your Data Management/Sharing Plans? Data Archiving? Compliance With NIH Public Access Policy?

Emory libraries provide a number of services to assist researchers in developing proposals.  Emory’s libraries provide access to resources that can aid in pre-award and post-award research administration. Examples of services available include help with data management planning, data archiving, public access compliance, and more. To learn more about how the Emory libraries can help […]

Also posted in Announcements, NIH, NSF, ORA, OSP, OTT, RAS, RGC | Comments closed

Office of Research Compliance Calendar of Upcoming Events

Also posted in ORC | Comments closed

Compliance Awareness

The Emory University Office of Research Compliance posted to their website guidance regarding obtaining prescription drugs and/or controlled substances for use in animal or bench research.  The guidance addresses frequently asked questions in order to assist Emory researchers with information related to state of Georgia and federal law requirements. Information on controlled substances in research, […]

Also posted in COI, ORA, ORC, OSP | Comments closed

Uniform Guidance: New Information Brings Some Good News and More Questions…

Uniform Guidance:  New Information Brings Some Good News and More Questions… Over the past month, additional information regarding the implementation of Uniform Guidance has been provided (verbally) by federal representatives at the FDP (Federal Demonstration Partnership) Meeting.  While some information shared was very positive, other information adds complexity to how we will need to administer […]

Also posted in Announcements, NIH, NSF, OCR, ORA, OSP | Tagged | Comments closed

National Science Foundation (NSF) Updates the Proposal and Award Policies and Procedures Guides (PAPPG)

The National Science Foundation has recently updated their Proposal and Award Policies and Procedures Guide (PAPPG). Many of the changes made in the PAPPG are related to the issuance of the new Uniform Guidance (2 CFR § 200) and references within the Guide have been updated to reflect the new Uniform Guidance rather than the […]

Also posted in Announcements, ERAZ, NSF, OCR, ORA, OSP, RGC | Comments closed

Office of Research Administration Newsletter’s New Web Address

In 2013 the Office of Research Administration Newsletter was transitioned to an online format using one of Emory’s web tools.  This year, we were asked to move our newsletter to a new institutional tool.  This task is complete.  The July/August 2014 edition of Emory’s Research Administration Newsletter is available at:  https://scholarblogs.emory.edu/ranews.  Please update any bookmarks […]

Also posted in Announcements, Audit, Cayuse Tips, COI, Compass, Cost Transfer, ERAZ, IACUC, IRB, OCR, ORA, ORC, OSP, OTT, RAS, RGC, Training | Leave a comment

Process For Review of Confidentiality/ Non-Disclosure Agreements

In an effort to improve efficiency and the handling of confidential/non-disclosure agreements (CDAs/NDAs), the OSP Contracts Unit has established a listserv e-mail address to send CDAs requiring review and institutional signature. Effective February 1, 2012, all clinical trial related CDAs/NDAs requiring review and institutional signature should be sent to the listserv e-mail. The listserv e-mail […]

Also posted in OSP | Tagged , , | Comments closed